Literature DB >> 62190

Inhibitor of drug-protein binding in "Vacutainers".

K M Piafsky, O Borga.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 62190     DOI: 10.1016/s0140-6736(76)90927-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Fluphenazine, trifluoperazine and perphenazine in Vacutainers.

Authors:  K K Midha; J K Cooper; Y D Lapierre; J W Hubbard
Journal:  Can Med Assoc J       Date:  1981-02-01       Impact factor: 8.262

2.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

Review 3.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

4.  Alteration of drug-protein binding in renal disease.

Authors:  M M Reidenberg; D E Drayer
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

5.  Spurious detection of a high serum imipramine level due to coating of Vacutainer stopper.

Authors:  P Dorian; E M Sellers; K L Reed
Journal:  Can Med Assoc J       Date:  1982-09-15       Impact factor: 8.262

Review 6.  Free drug concentration monitoring in clinical practice. Rationale and current status.

Authors:  C K Svensson; M N Woodruff; J G Baxter; D Lalka
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

7.  Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma.

Authors:  E Pike; B Skuterud; P Kierulf; D Fremstad; S M Abdel Sayed; P K Lunde
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

8.  Do evacuated blood collection tubes interfere with therapeutic drug monitoring?

Authors:  R Janknegt; J J Lohman; P M Hooymans; F W Merkus
Journal:  Pharm Weekbl Sci       Date:  1983-12-16

9.  Unsuitability of evacuated tubes for monitoring heparin therapy by activated partial thromboplastin time.

Authors:  A D Heyns; D J van den Berg; P H Kleynhans; P W du Toit
Journal:  J Clin Pathol       Date:  1981-01       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.